
Common name
cyclopropanamine
IUPAC name
cyclopropanamine
SMILES
NC1CC1
Common name
cyclopropanamine
IUPAC name
cyclopropanamine
SMILES
NC1CC1
INCHI
InChI=1S/C3H7N/c4-3-1-2-3/h3H,1-2,4H2
FORMULA
C3H7N

Common name
cyclopropanamine
IUPAC name
cyclopropanamine
Molecular weight
57.094
clogP
0.580
clogS
0.064
Frequency
0.0014
HBond Acceptor
0
HBond Donor
2
Total PolarSurface Area
26.02
Number of Rings
1
Rotatable Bond
0
Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
---|---|---|---|---|
FDBD00616 | Tranylcypromine |
![]() |
Anti-Anxiety Agents; Antidepressive Agents; Monoamine Oxidase Inhibitors; Nervous System; Antidepressants; Psychoanaleptics; Monoamine Oxidase Inhibitors, Non-Selective; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2A6 Inhibitors; CYP2A6 Inhibitors (strong); CYP2A6 Inhibitors (moderate); CYP2A6 Inducers; CYP2A6 Inducers (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP2E1 Inhibitors; CYP2E1 Inducers; CYP2E1 Inducers (strong); CYP3A4 Inhibitors; | For the treatment of major depressive episode without melancholia. |
FDBD00900 | Abacavir |
![]() |
Anti-HIV Agents; Reverse Transcriptase Inhibitors; Antiinfectives for Systemic Use; Direct Acting Antivirals; Antivirals for Systemic Use; Nucleoside and Nucleotide Reverse Transcriptase Inhibitors; | For the treatment of HIV-1 infection, in combination with other antiretroviral agents. |
FDBD01529 | Ticagrelor |
![]() |
Platelet Aggregation Inhibitors; Antithrombotic Agents; Blood and Blood Forming Organs; Platelet Aggregation Inhibitors Excl. Heparin; Purinergic P2Y Receptor Antagonists; CYP3A4 Inhibitors; | For the prevention of thrombotic events (for example stroke or heart attack) in patients with acute coronary syndrome or myocardial infarction with ST elevation. |
FDBD01653 | Corticorelin |
![]() |
Diagnostic Agents; Tests for Pituitary Function; | Corticorelin is indicated for use in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome. |
4 ,
1
FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
---|---|---|---|---|---|
4n1u_ligand_1_2.mol2 | 4n1u | 1 | -6.11 | C1C(C1)[NH3+] | 4 |
1tnl_ligand_frag_0.mol2 | 1tnl | 1 | -5.80 | C1(CC1)[NH3+] | 4 |
4dli_ligand_1_2.mol2 | 4dli | 1 | -5.80 | [NH3+]C1CC1 | 4 |
2b8l_ligand_frag_0.mol2 | 2b8l | 1 | -5.77 | [NH3+]C1CC1 | 4 |
3be9_ligand_1_1.mol2 | 3be9 | 1 | -5.76 | [NH3+]C1CC1 | 4 |
3ej1_ligand_1_1.mol2 | 3ej1 | 1 | -5.76 | [NH3+]C1CC1 | 4 |
5alb_ligand_1_4.mol2 | 5alb | 1 | -5.76 | [NH3+]C1CC1 | 4 |
1h37_ligand_1_5.mol2 | 1h37 | 1 | -5.74 | [NH3+]C1CC1 | 4 |
528 ,
53